JPRN-UMIN000010033已完成未知
To investigate the efficacy of tocilizumab in RA patients with moderate disease activity under biologic therapy - To investigate the efficacy of tocilizumab in RA patients with moderate disease activity
Daihei Kida0 个研究点目标入组 20 人开始时间: 2013年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have serious infection 2)Patients who have history of severe allergic or anaphylactic reactions to human, humanized or murine monoclonal antibodies 3)Patients who have history of a malignant tumor, or who have malignant tumor 4)Patients who have serious cardiac disease or liver disease, renal damage 5)Pregnant women or women trying to get pregnant 6)Patients considered inappropriate judged by attending physicians
研究者
相似试验
已完成
不适用
Efficacy and safety of tocilizumab in RA patients in daily clinical practice: An retrospective observational studyRheumatoid ArthritisJPRN-UMIN000006956niversity of Occupational and Environmental Health, Japan250
已完成
不适用
Success of tocilizumab in RA patients with remission induction and sustained efficacy after discontinuatiorheumatoid arthritisJPRN-UMIN000002744Keio University300
招募中
3 期
Evaluation of The effect of tocilizumab on patients with severe Covid 19IRCT20210408050899N1Ahvaz University of Medical Sciences15
已完成
不适用
The efficacy of tocilizumab to patients with rheumatoid arthritis refractory to anti-TNF agents: the open trialrheumatoid arthritisJPRN-UMIN000001240Division of Rheumatology & Clinical Immunology, Jichi Medical University20
已完成
3 期
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to DMARDs or Anti-TNFRheumatoid ArthritisNCT01326962Hoffmann-La Roche28